Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Oustrebuplicanson Dec 28, 2018 2:33pm
92 Views
Post# 29165729

RE:I've been busy buying all morning

RE:I've been busy buying all morning

 

Last Price
61.26
Day Change
0.560.92%
 
Fri Dec 28, 2018
 
02:17 PM
 
USD
 
Delayed
Bid
61.26
Bid Size
3
Ask
61.30
Ask Size
1
High
62.88
Low
59.57
Volume
763,253
Prev Close
60.70
Open
61.57
52wk High
82.85
52wk Low
37.36
52W H (Date)
12/03/2018
52W L (Date)
04/06/2018
Fwd Div Yield
--
Div Yield
--
Mkt Cap
7.46 bil
Mkt Cp less Prv Shrs
7.51 bil
Avg Vol
1.93 mil
Shares
122.90 mil
P/E Forward
-63.694
P/B
10.408
P/S
18.483
P/CF
--
EPS
-1.170
Beta
3.132
1D Ret
2.09%
1W Ret
3.30%
1M Ret
-12.99%
3M Ret
-20.85%
6M Ret
0.43%
1Y Ret
14.27%
2Y Ret
108.30%
3Y Ret
85.50%
5Y Ret
37.75%
10Y Ret
60.06%
15Y Ret
13.21%
YTD Ret
15.53%
VWAP
60.830
Trade Exch
BATS
FYE
Dec
Ex-Div Date
--
Dividend
--
Open Interest
--
Expiry Date
--
Strike Price
--

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities